Glaxosmithkline Intellectual Property Development Limited

Joanna Opalinska

Patrick A Mayes

Sanjay Khandekar

Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and a proteasome inhibitor (e.g. bortezomib). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).

Treatment for primary amyloidosis with anti-BCMA binding protein

Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory drug (e.g. pomalidomide or lenalidomide). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).

Growing community of inventors

Collegeville, PA, United States of America

Joanna Opalinska